GOG 0277

Trial Description: 
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observtion in Treating Patients with High Risk Uterine Leiomyosarcoma Previously removed by Surgery
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Uterine Leiomyosarcoma
Trial Status: 
Completed